The longevity brand of Inside Out Biotech, VIVE-LONDON, has launched VIVE-GLYNAC, a new glutathione-precursor supplement designed to support cellular health. According to the company, VIVE-GLYNAC contains 300mg of N-acetylcysteine and
The International Society of Aesthetic Plastic Surgery (ISAPS) has published its survey of aesthetic procedures performed in 2025. Drawing on responses from 2,900 plastic surgeons worldwide, botulinum toxin remained the
The latest research highlights from Professor Sebastian Cotofana Key Takeaways Title: Understanding Facial Ageing Through Facial Biomechanics: A Clinically Applicable Guide for Improved Outcomes Authors: Lysander Freytag et al. Published:
Explore the most innovative products launched over the past year Working in such a fast-moving and rapidly evolving field, whether as a practitioner, clinic owner or specialty professional, it can
The Department of Health and Social Care (DHSC) has announced a consultation on proposals to restrict high-risk cosmetic procedures in England to regulated healthcare professionals. The consultation follows the Government’s
Dermo-cosmetic system Elementrē is now exclusively available to UK practitioners through Cosmedi Clinical skincare works when three conditions are met: the active is present at an effective concentration, it is
Aesthetics rounds up the latest company appointments announced within the aesthetics community Pharmaceutical company Galderma has announced the appointment of Juan Rodrigo Betancur as general manager for UK and Ireland.
The Joint Council for Cosmetic Practitioners (JCCP) has released guidance intended to help registrants achieve and maintain compliance when advertising non-surgical cosmetic procedures. The guidance follows observations by the Professional
A BBC News investigation has highlighted concerns about complications reported by patients following lower-cost upper eyelid blepharoplasty performed abroad. One patient, Nikita Morgan, travelled from Dublin to Düsseldorf (Faceland) in
Ontario, Canada’s nursing regulator has proposed changes intended to prevent the delegation of aesthetic injectable procedures to unsupervised, unregulated staff. The College of Nurses of Ontario (CNO) previously issued guidance
